XML 19 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Jun. 30, 2012
CURRENT ASSETS:    
Cash and cash equivalents $ 27,821 $ 9,389
Short term bank deposits 22,960 21,397
Marketable securities 9,045 7,023
Other accounts receivable and prepaid expenses 1,284 383
Total current assets 61,110 38,192
LONG-TERM ASSETS:    
Long-term deposits and restricted deposits 789 1,287
Advance payment for leasehold improvements 113 2,400
Property and equipment, net 11,501 5,019
Severance pay fund 775 522
Other long term assets 49   
Total long-term assets 13,227 9,228
Total assets 74,337 47,420
CURRENT LIABILITIES    
Trade payables 2,577 1,368
Accrued expenses 780 922
Deferred revenues 779 779
Advance payment from United Therapeutics 567 1,576
Other accounts payable 1,062 877
Total current liabilities 5,765 5,522
LONG-TERM LIABILITIES    
Deferred revenues 2,921 3,505
Accrued severance pay 923 651
Other long term liabilities 709   
Total long term liabilities 4,553 4,156
COMMITMENTS AND CONTINGENCIES      
STOCKHOLDERS' EQUITY    
Common stock $0.00001 par value: Authorized: 100,000,000 shares Issued and outstanding: 58,674,520 shares as of March 31, 2013, 46,448,051 shares as of June 30, 2012      
Additional paid-in capital 143,356 103,619
Accumulated deficit (79,912) (65,747)
Other comprehensive gain (loss) 575 (130)
Total stockholders' equity 64,019 37,742
Total liabilities and stockholders' equity $ 74,337 $ 47,420